Characteristics of Published Studies I (n = 12)
| Study | Country | Disease | Indication | No. of patients randomized/analyzed | Period of recruitment | Mean follow-up (mo) |
| Beanlands et al. 2007 (PARR-2) (23,24) | Canada | Coronary heart disease | Detection of viable myocardium | PET: 218/218 | 06/2000–09/2004 | 12 |
| CG: 212/212 | ||||||
| Fisher et al. 2009 (25) | Denmark | NSCLC | Staging (preoperative) | PET/CT: 98/98 | 01/2002–02/2007 | 27 |
| CG: 91/91 | ||||||
| Herder et al. 2006 (26) | The Netherlands | NSCLC | Staging | PET: 232/232 | 09/1999–06/2001 | 12 |
| CG: 233/233 | ||||||
| Maziak et al. 2009 (14) | Canada | NSCLC | Staging | PET/CT: 170/167 | 06/2004–08/2007 | CG: 22.5 |
| CG: 167/162 | PET/CT: 21.8 | |||||
| Picardi et al. 2007 (20) | Italy | Hodgkin lymphoma | Restaging | No radiation: 80/80 | No information | 40 |
| Radiation: 80/80 | ||||||
| Plewnia et al. 2007 (27) | Germany | Chronic tinnitus | Localization | Crossover study | No information | <1 |
| 6/6 | ||||||
| Ruers et al. 2009 (13) | The Netherlands | Recurrent colorectal cancer | Staging | PET/CT: 75/75 | 05/2002–02/2006 | 36 |
| CG: 75/75 | ||||||
| Siebelink et al. 2001 (28) | The Netherlands | Coronary heart disease | Diagnosis | PET: 49/49 | No information | PET: 28 |
| CG: 54/54 | CG: 29 | |||||
| Sobhani et al. 2008 (29) | France | Colorectal cancer | Diagnosis of recurrence | PET: 65/65 | 01/2001–06/2004 | 24 |
| CG: 65/65 | ||||||
| van Tinteren et al. 2002 (PLUS) (30,31) | The Netherlands | NSCLC | Staging (primary) | PET: 92/92 | 01/1998–01/1999 | 12 |
| CG: 96/96 | ||||||
| Tsai et al. 2010 (32) | Taiwan | Cervical cancer | Staging (diagnosis lof metastases) | PET: 66/66 | 01/2002–04/2006 | 53 |
| CG: 65/65 | ||||||
| Viney et al.2004 (33) | Australia | NSCLC | Staging | PET: 91/91 | 04/1999–12/2000 | 12 |
| CG: 92/92 |
CG = control group.